EP 146: Bio Europe - Will Europe’s Biotech Future Survive? Inside the Funding and Talent Exodus

Europe’s biotech sector is facing a crisis: despite its scientific achievements, it struggles with funding gaps and an exodus of top talent to the US. As biotech innovations drive global healthcare, Europe risks losing its edge—and the potential for groundbreaking medical advancements that affect us all. How can Europe regain its competitive advantage and transform scientific discoveries into real-world solutions?

In this special episode from BIO-Europe’s 30th anniversary in Stockholm, industry veterans Cormac Sheridan, Jonathan Smith, Christian Soschner, and Mike Ward reveal the path forward. They tackle the critical challenges in Europe’s biotech landscape, from funding shortfalls and talent loss to opportunities in AI and the promise of global partnerships. Discover the strategies that could redefine Europe’s role in biotech and keep innovation thriving on the continent.

🎙️ What’s Inside:

1️⃣ The Funding Dilemma: Why Europe’s investment landscape hinders biotech and how new models could change the game.
2️⃣ Talent Exodus: How the brain drain to the US is affecting Europe’s biotech ambitions and what it takes to retain top innovators.
3️⃣ AI in Biotech: Uncover the power of AI and digital tools in transforming drug development and patient care in Europe.
4️⃣ Global Collaboration Opportunities: Why Europe needs to shift its focus eastward and the potential of partnerships beyond US borders.

👤 Meet the Panelists:

• Cormac Sheridan: A seasoned biotech journalist, covering industry trends for over two decades, who reminds us that biotech’s success is rooted in resilience: “Fail faster, fail better.”
• Jonathan Smith: Biotech correspondent with insights into the complex regulatory and financial hurdles in Europe’s biotech ecosystem.
• Christian Soschner: CEO and biotech advisor, who shares powerful strategies on funding, partnerships, and global competitiveness.
• Mike Ward: Renowned analyst with a keen eye on market dynamics and investment trends shaping the future of biotech.
• Millie Nelson: Panel Host

  💡 QUOTES:

(05:18) "The future of biotech lies in integrating AI into medicine—beyond the hype." – Cormac Sheridan

(00:17:22) "Failure is embedded in biotech. It's a risk-based enterprise; success demands resilience." – Cormac Sheridan

(00:22:39) "and this brain drain when someone has a great idea that has..." - Christian Soschner

  ⏰ Timestamps: 

(00:00) Meet the panelists - industry experts with decades of biotech insight
(07:15) Innovative funding paths and geopolitical impacts in biotech
(06:30) Navigating Global Investment Challenges
(00:16:07) Europe's biotech strength - powerful innovation, but struggles with commercializing scientific breakthroughs
(00:22:39) Brain drain in Europe - how US incentives pull top talent across the Atlantic
(00:29:06) Neuroscience breakthroughs - positive signs for neurodegenerative disease treatments spark new interest
(00:34:08) Europe’s opportunity - global collaboration could drive biotech growth beyond US partnerships

Join us as these experts explore how Europe can leverage its scientific heritage to remain a global biotech leader. This conversation is packed with insights on the future of AI, international partnerships, and what it takes to keep innovation alive in Europe.

👀 Stay Tuned: Watch the full episode to see how Europe’s biotech ecosystem can thrive in the

Send us a text

Support the show

Join the Podcast Newsletter: Link